A paradigm for the control of influenza

Journal of Infectious Diseases

Volumn 202, Issue 11, 2010, Pages 1619-1622

  Lewin, Edward B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; TRIPLE VACCINE;

EDITORIAL; HERD IMMUNITY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; PREVALENCE; PREVENTIVE MEDICINE; PRIMARY SCHOOL; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL HEALTH SERVICE;

ADOLESCENT; AGED; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; HUMANS; IMMUNITY, HERD; INFLUENZA VACCINES; INFLUENZA, HUMAN; PUBLIC HEALTH PRACTICE; SCHOOL HEALTH SERVICES;

EID: 78649584315     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/657090     Document Type: Editorial

References (53)

1. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis 2010; 202(11):1626-1633 (in this issue).
2. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996; 18:64-76.
3. Glezen WP. Herd protection against influenza. J Clin Virol 2006; 37:237-243.
4. Gaglani MJ, Piedra PA, Herschler GB, et al. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza (H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 2004; 158:65-73.
5. Halloran ME, Piedra PA, Longini IM, et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 2007; 25:4038-4045.
6. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-1548.
7. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct and indirect protection in children. Pediatrics 2007; 120:e553-e564.
8. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10-18 years of age in a community-based, non-randomized, open-label trial. Pediatrics 2005; 116:e397-e407. (Pubitemid 44339432)
9. Gaglani MJ, Piedra PA, Riggs M, et al. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr Infect Dis J 2008; 27:444-452.
10. Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity and vaccines. Semin Pediatr Infect Dis 1991; 2:140-146.
11. Glezen WP, Couch RP. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978; 298:587-592.
12. Glezen WP. Influenza infections in infants. Pediatr Infect Dis J 1997; 16:1065-1068.
13. Frank AL, Taber LH, Wells CR, et al. Patterns of shedding of myxoviruses in children. J Infect Dis 1981; 144:433-441.
14. Elveback LR, Fox JP, Ackerman E. An influena simulation model for immunization studies. Am J Epidemiol 1976; 103:152-165.
15. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospital rates in the United States. JAMA 2004; 292:1333-1340.
16. Molinari N, Ortega-Sanchez IR, Messonier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-5096.
17. Bridges CB, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recomendations of the ACIP. MMWR 2002; 51:1-31.
18. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recomendations of the ACIP. MMWR 2004; 53:1-40.
19. Smith NM, Bresee TS, Shay DK, et al. Prevention and control of influenza: recommendations of the ACIP. MMWR 2006; 55:1-42.
20. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: MMWR 2008; 57:1-60.
21. Centers for Disease Control and Prevention. Influenza vaccination coverage among children aged 6-23 months - United States, 2005-2006 season. MMWR 2007; 56:959-963.
22. Centers for Disease Control and Prevention. Influenza vaccine coverage among children 6-59 months - six immunization sites, United States, 2006-2007 influenza season. MMWR 2007; 56:963-965.
23. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the ACIP, 2009. MMWR 2009; 58:1-52.
24. Kim H, Raymond P, Paine V, Cain R, Viner-Brown S. Seasonal influenza vaccination coverage among pregnant women in Rhode Island. Med Health R I 2009; 92:345-347.
25. Goodwin K, Vibond C, Simonsen L. Antibody responses in the elderly: a quantitative review. Vaccine 2006; 24:1159.
26. Simonsen L, Reichert TA, Blackwelder WC, et al. Impact of influenza vaccination on seasonal mortality in the U.S. elderly population. Arch Intern Med 2005; 165:265.
27. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179.
28. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35:337-344.
29. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality. Int J Epidemiol 2006; 35:345-352.
30. Glezen WP. Herd protection against influenza. J Clin Virol 2006; 37:237-243.
31. John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol 2000; 16:601-606.
32. Glanz JM, McClure DC, Magid DF, et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics 2009; 123:1446-1451.
33. Jansen VA, Stollenwork N, Jensen ME, et al. Measles outbreaks in a population with declining vaccine uptake. Science 2003; 301:804.
34. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic, 2005. BMJ 2005; 330:1132-1135.
35. Fry AM, Lurie P, Gidley M, et al. Haemophilus influenzae type b disease among Amish children in Pennsylvania: reasons for persistent disease. Pediatrics 2001; 108:e60-e68.
36. Kwong JC, Staker J, Lim J, et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008; 5:e211.
37. Robertson SE, Featherstone D, Gacic-Dobo M, et al. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica 2003; 14:306-315. (Pubitemid 38056800)
38. Monto AS, Davenport FM, Napier JA, et al. Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic. Bull WHO 1969; 41:537-542.
39. Reichert AR. The Japanese program of vaccination of schoolchildren against influenza: implications for the control of the disease. Semin Pediatr Inf Dis 2002; 13:104-111.
40. Piedra AA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of trivalent live attenuated vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-1548.
41. Rudenko IG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactive influenza vaccine in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 1993; 168:881-887.
42. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of daycare children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:1677-1682.
43. Ghendon YZ, Kaira AN, Elshina GA. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134:71-78.
44. King JC, Cummings GE, Stoddard J, et al. A pilot study of the effectiveness of a school-based influenza vaccination program. Pediatrics 2005; 116:e868-e873.
45. Ambrose CS, Wu X, Belshe RB. The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time post vaccination. Pediatr Infect Dis J 2010; 29:1-6.
46. Weycker D, Edelsberg J, Halloran ME, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23:1284-1293.
47. Oshinsky D. Polio: an American story. Oxford University Press, 2005.
48. Dobson S. Assessment of a universal school-based hepatitis B vaccination program. JAMA 1995; 274:1209-1213.
49. Beilenson P, Santelli J. An urban school-based voluntary MMR booster immunization program. J School Health 1992; 62:71-73.
50. Belshe RB, Edwards K, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007; 356:685-696.
51. Jefferson T, Demichili A, Hamden A et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: a systemic review. Lancet 2005; 365:773-780. (Pubitemid 40311364)
52. Ambrose CS, Tingting Y, Walker R, et al. Duration of protection provided by LAIV in children. Pediatr Infect Dis J 2008; 27:744-748.
53. Fleming MB, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents. Pediatr Infect Dis J 2006; 25:860-868.